7EZC image
Deposition Date 2021-06-01
Release Date 2022-04-13
Last Version Date 2024-11-20
Entry Detail
PDB ID:
7EZC
Title:
Adenosine A2a receptor mutant-I92N
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Escherichia coli (Taxon ID: 562)
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.80 Å
R-Value Free:
0.31
R-Value Work:
0.28
R-Value Observed:
0.28
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Adenosine receptor A2a,Soluble cytochrome b562
Gene (Uniprot):cybC, ADORA2A
Mutations:I92N,M1007W
Chain IDs:A, B
Chain Length:431
Number of Molecules:2
Biological Source:Homo sapiens, Escherichia coli
Ligand Molecules
Primary Citation
Crystal structure of a constitutive active mutant of adenosine A 2A receptor.
Iucrj 9 333 341 (2022)
PMID: 35546802 DOI: 10.1107/S2052252522001907

Abstact

The adenosine A2A receptor (A2AAR) is a prototypical member of the class A subfamily of G-protein-coupled receptors (GPCRs) that is widely distributed in various tissues and organs of the human body, and participates in many important signal-regulation processes. We have previously summarized a common activation pathway of class A GPCRs in which a series of conserved residues/motifs undergo conformational change during extracellular agonist binding and finally induce the coupling of intracellular G protein. Through this mechanism we have successfully predicted several novel constitutive active or inactive mutations for A2AAR. To reveal the molecular mechanism of mutation-induced constitutive activity, we determined the structure of a typical mutant I92N complexed with the agonist UK-432097. The mutated I92N forms a hydrophilic interaction network with nearby residues including Trp6.48 of the CWxP motif, which is absent in wild-type A2AAR. Although the mutant structure is similar overall to the previously determined intermediate-state A2AAR structure (PDB ID 3qak) [Xu, Wu, Katritch, Han, Jacobson, Gao, Cherezov & Stevens (2011). Science, 332, 322-327 ▸], molecular dynamics simulations suggest that the I92N mutant stabilizes the metastable intermediate state through the hydrophilic interaction network and favors the conformational transition of the receptor towards the active state. This research provides a structural template towards the special pharmacological outcome triggered by conformational mutation and sheds light on future structural or pharmaco-logical studies among class A GPCRs.

Legend

Protein

Chemical

Disease

Primary Citation of related structures